Abstract
The neologism “trace amines” was first adopted by a study group held under the auspices of the American College of Neuropsychopharmacology at its Puerto Rico meeting in 1975. The first book1 on this topic recorded the papers presented by the participants of this study group. The definition of a trace amine2 appears to include those monoamines whose tissue concentrations lie between 0.1 and 100 ng/g. That it is an inappropriate term follows from the fact that some of the well-known trace amines can exist in some tissues in amounts considerably in excess of 100 ng/g and indeed, in the presence of appropriate monoamine oxidase inhibitors, many of them exceed this level; it is also a fact that some of the well-known putative monoamine neurotransmitters may be present in trace quantities in some locations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Usdin, E., and Sandler, M. (eds.), 1976, Trace Amines and the Brain, Marcel Dekker, New York.
Boulton, A. A., 1974, Lancet 2: 7871.
Durden, D. A., and Philips, S. R., 1980, J. Neurochem. 34: 1725–1732.
Boulton, A. A., 1976, Trace Amines and the Brain, (E. Usdin and M. Sandler. eds.), Marcel Dekker, New York, pp. 21–39.
Boulton, A. A., 1979, Behay. Brain Sci. 2: 418.
Durden, D. A., Davis, B. A., and Boulton, A. A., 1974, Biomed. Mass Spectrom. 1: 83–95.
Durden, D. A., 1978, Research Methods in Neurochemistry, Volume 4 (N. Marks and R. Rodnight, eds.), Plenum Press, New York, pp. 205–250.
Durden, D. A., and Boulton, A. A., 1979, Techniques in the Life Sciences B2/11 (H. L. Kornberg, H. Metcalfe, D. Northcote, C. Pogson, and K. Tipton, eds.), Elsevier/North Holland, Amsterdan, pp. B214 1–25.
Davis, B. A., Durden, D. A., and Boulton, A. A., 1980, Recent Advances in Mass Sprectrometry and Medicine, Volume 6 ( D. Frigerio and M. McCamish, eds.), Elsevier/North Holland, Amsterdam, pp. 83–93.
Willner, J., LeFevre, H. F., and Costa, E., 1974, J. Neurochem. 23: 857–859.
Warsh, J. J., Godse, D. D., Stancer, H. C., Chan, P. N., and Coscina, D. V., 1977, Biochem. Med. 18: 10–20.
Karoum, F., Nasrallah, H., Potkin, S., Chuang, L., Moyer-Schwing, J., Phillips, I., and Wyatt, R. J., 1979, J. Neurochem., 33: 201–212.
Danielson, T. J., Boulton, A. A., and Robertson, H. A., 1977, J. Neurochem. 29: 1131–1135.
McCaman, M. W., and McCaman, R. E., 1978, Brain Res. 141: 347–352.
David, J. C., and Delacour, J., 1980, Brain Res. 195: 231–235.
Philips, S. R., 1981, Advances in Cellular Neurobiology, Volume 2 (L. Hertz and S. Federoff, eds.), Academic Press, New York pp. 355–391.
Saavedra, J. M., 1974, J. Neurochem. 22: 211–216.
Suzuki, O., and Yagi, K., 1976, Anal. Biochem. 75: 192–200.
Martin, I. L., and Baker, G. B., 1976, J. Chromatogr. 123: 45–50.
Baker, G. B., Coutts, R. T., and LeGatt, D. F., 1980, Can. J. Neurol. Sci. 7: 235.
Barger, G., and Dale, H. H., 1910, J. Physiol. ( Lond. ) 41: 19–59.
Asatoor, A. M., and Dalgliesh, C. E., 1959, Biochem. J. 73: 26 P.
Jepson, J. B., Lovenberg, W., Zaltzman, P., Oates, J. A., Sjoerdsma, A., and Udenfriend, S., 1960, Biochem. J. 74: 5 P.
Randrup, A., and Munkvad, I., 1966, Acta Psychiat. Scand. [Suppl.] 191: 193–199.
Fischer, E., Ludmer, R. I., and Sabelli, H. C., 1967, Acta Physiol. Lat. Am. 17: 15–21.
Mantegazza, P., and Riva, M. J., 1963, J. Pharm. Pharmacol. 15: 472–478.
Philips, S. R., Rozdilsky, B., and Boulton, A. A., 1978, Biol. Psychiatry 13: 51–57.
Mosnaim, A. D., and Luwang, E. E., 1973, Anal. Biochem. 54: 561–577.
Durden, D. A., Philips, S. R., and Boulton, A. A., 1973, Can. J. Biochem. 51: 995–1002.
Saavedra, J. M., 1974, Anal. Biochem. 59: 628–633.
Philips, S. R., Durden, D. A., and Boulton, A. A., 1974a, Can. J. Biochem. 52: 366–373.
Philips, S. R., Davis, B. A., Durden, D. A., and Boulton, A. A., 1975, Can. J. Biochem. 53: 65–69.
Molinoff, P. B., and Axelrod, J., 1969, Science 164: 428–429.
Philips, S. R., Durden. D. A., and Boulton, A. A., 1974, Can. J. Biochem. 52: 447–451.
Saavedra, J. M., and Axelrod, J., 1972, J. Pharmacol. Exp. Ther. 182: 363–369.
Tallman, J. F., Saavedra, J. M.. and Axelrod, J., 1976, J. Pharmacol. Exp. Ther. 199: 216–221.
Sloan, J. M., Martin, W. R., Clements, T. H., Buchwald, W. F., and Bridges, S. R., 1975, J. Neurochem. 24: 523–532.
Fischer, E., Spatz, H., Heller, B., and Reggiani, H., 1972, Experientia 28: 307–308.
Snodgrass, S. R., and Horn, A. S., 1973, J. Neurochem. 21: 687–696.
Boulton, A. A., Juorio, A. V., Philips, S. R., and Wu, P. H., 1975, Brain Res. 96: 212–216.
Borison, R. L., Mosnaim, A. D., and Sabelli, H. C., 1974, Life Sci. 15: 1837–1848.
Faraj, B. A., Mu, J.-Y., Lewis, M. S., Wilson, J. P., Israili, Z. H., and Dayton, P. G., 1975, Proc. Soc. Exp. Biol. Med. 149: 664–669.
Mosnaim, A. D., Inwang, E. E., and Sabelli, H. C., 1974, Biol. Psychiatry 8: 227–234.
Gunne, L.-M., and Jonsson, J., 1965, Acta Physiol. Scand. 64: 434–438.
Juorio, A. V., 1976, Brain Res. 111: 442–445.
Juorio, A. V., and Philips, S. R., 1976, Neurochem. Res. 1: 501–509.
Robertson, H. A., 1976, Experientia 32: 552–553.
Juorio, A. V., and Robertson, H. A., 1977, J. Neurochem. 28: 573–579.
Danielson, T. J.. Wishart, T. B., and Boulton, A. A., 1976. Life Sci. 18: 1237–1244.
Boulton, A. A., Juorio, A. V., Philips, S. R., and Wu, P. H., 1977, Br. J. Pharmacol. 59: 209–214.
Philips, S. R., 1978, Noncatecholic Phenylethylamines (A. D. Mosnaim, and M. E. Wolf, eds.), Marcel Dekker, New York and Basel, pp. 113–138.
Juorio, A. V., and Danielson, T. J., 1978, Eur. J. Pharmacol. 50: 79–82.
Spector, S., Melmon, K., Lovnberg, W., and Sjoerdsma, A., 1963, J. Pharmacol. Exp. Ther. 140: 229–235.
Wu, P. H., and Boulton, A. A., 1975, Can. J. Biochern. 53: 42–50.
Giardina, W. J., Pedemonte, W. A., and Sabelli, H. C., 1973, Life Sci. 12: 153–161.
Henwood, R. W., Boulton, A. A., and Phillis, J. W., 1979, Brain Res. 164: 247–351.
Jones, R. S. G., and Boulton, A. A., 1980, Can. J. Physiol. Pharmacol. 58: 222–227.
Snodgrass, S. R., 1974, J. Pharm. Pharmacol. 26: 931–936.
Philips, S. R., and Boulton, A. A., 1979, J. Neurochem. 33: 159–167.
Yang, H.-Y. T., and Neff, N. H., 1973, J. Pharmacol. Exp. Ther. 187: 365–371.
Boulton, A. A., 1979, Int. Rev. Biochem. 26: 179–206.
Oldendorf, W. H., 1971, Am. J. Physiol. 221: 1629–1639.
Boulton, A. A., and Baker, G. B., 1975, J. Neurochem. 25: 477–481.
Shore, P. A., Silver, S. L., and Brodie, B. B., 1955, Science 122: 284–285.
Holzbauer, M., and Vogt, M., 1956, J. Neurochem. 1: 8 - I1.
Bertler, A., 1961, Acta Physiol. Scand. 51: 75–83.
Fuxe, K., Grobecker, H., and Jonsson, J., 1967, Eur. J. Pharmacol. 2: 202–207.
Jonsson, J., Grobecker, H., and Holtz, P., 1966, Life Sci. 5: 2235–2246.
Jackson, D. M., and Smythe, D. B., 1973, Neuropharmacology 12: 663–668.
Baker, G. B., Raiteri, M., Bertollini, A., Del Carmine, R., Keane, P. E., and Martin, I. L., 1976, J. Pharm. Pharmacol. 28: 456–457.
Schmitt, R., and Nasse, O., 1865, Liebigs Ann. Chem. 133: 211–216.
Barger, G., 1909, J. Chem. Soc. 95: 1123–1129.
Henze, M., 1913, Hoppe Seylers Z. Physiol. Chem. 87: 51–58.
Nishimura, T., and Gjessing, L. R., 1966, Scand. J. Clin. Lab. Invest. 18: 217–220.
King, G. S., Goodwin, B. L., Ruthven, C. R. J., and Sandler, M., 1974, Clin. Chim. Acta 51: 105–107.
Boulton, A. A., Dyck, L. E., and Durden, D. A., 1974, Life Sci. 15: 1673–1683.
Boulton, A. A., and Dyck, L. E., 1974, Life Sci. 14: 2497–2506.
Mitoma, C., Posner, H. S., Bogdanski, D. F., and Udenfriend, S., 1957, J. Pharmacol. Exp. Ther. 120: 188–194.
Majer, J. R., and Boulton, A. A., 1970, Nature 225: 658–660.
Boulton, A. A., and Majer, J. R., 1970, J. Chromatogr. 48: 322–327.
Boulton, A. A., and Majer, J. R., 1971, Can. J. Biochem. 49: 993–998.
Faraj, B. A., Dayton, P. G., Camp, V. M., Wilson, J. P.. Maivean, E. J., and Schlant, R. C., 1977, J. Pharmacol. Exp. Ther. 200: 384–393.
Tallman, J. C., Saavedra, J. M., and Axelrod, J., 1976, J. Neurochem. 27: 465–469.
Juorio, A. V., 1977, Brain Res. 126: 181–184.
Juorio, A. V., 1977, Life Sci. 20: 1663–1668.
Juorio, A. V., 1979, Br. J. Pharmacol. 66: 377–384.
Juorio, A. V., 1980, Br. J. Pharmacol. 70: 475–480.
Bevan, P., Bradshaw, C. M., Pun, R. Y. K., Slater, N. T., and Szabadi, E., 1978, Br. J. Pharmacol. 63: 651–657.
Boulton, A. A., and Wu, P. H., 1973, Can. J. Biochem. 51: 428–435.
Fellman, J. H., Roth, G. S., and Fujita, T. S., 1976, Arch. Biochem. Biophys. 174: 562–567.
Boulton, A. A., and Quan, L., 1970, Can. J. Biochem. 48: 1287–1291.
Brandau, K., and Axelrod, J., 1972, Naunyn-Schmiedebergs Arch. Pharmacol. 273: 123–133.
Silkaitis, R. P., and Mosnaim, A. D., 1976, Brain Res. 114: 105–115.
Mosnaim, A. D., Edstrand, D. L., Wolf, M. E., and Silkaitis, R. P., 1977, Biochem. Pharmacol. 26: 1725–1728.
Davis, B. A., and Boulton, A. A., 1980, Eur. J. Mass Spectrom. Med. Envir. Res. 1: 149–153.
Ewins, A. J., and Laidlaw, P. P., 1910, J. Physiol., 41: 78–87.
Blaschko, H., Richter, D., and Schlossmann, H., 1937, Biochem. J. 31: 2187–2196.
Yu, P. H., and Boulton, A. A., 1980, J. Neurochem. 35: 255–257.
Wu, P. H., and Boulton, A. A., 1974, Can. J. Biochem. 52: 374–381.
Philips, S. R., Baker, G. B., and McKim, H. R., 1980, Experientia 36: 241–242.
Juorio, A. V., Davis, B. A., and Boulton, A. A., 1980, Res. Commun. Psychol. Psychiatry Behay. 5: 255–264.
Durden, D. A., and Boulton, A. A., 1981, J. Neurochem. 36: 129–135.
Davis, B. A., Durden, D. A., Li, P. P., and Boulton, A. A., 1977, J. Chromatogr. 142: 517–522.
McQuade, P. S., Juorio, A. V., and Boulton, A. A., 1981, J. Neurochem. 37: 735–739.
Karoum, F., Gillin, J. C., Wyatt, R. J., and Costa, E., 1975, Biomed. Mass Spectrom. 2: 183–189.
Karoum, F., Wyatt, R. J., and Majchrowicz, E., 1976, Br. J. Pharmacol. 56: 403–411.
Yu, P. H., and Boulton, A. A., 1979, Can. J. Biochem. 57: 1204–1209.
Buck, S. H., Murphy, R., and Molinoff, P. B., 1977, Brain Res., 122: 281–297.
Harmar, A. J., and Horn, A. S., 1976, J. Neurochem., 26: 987–993.
Juorio, A. V., 1980, Catecholamines and Stress: Recent Advances (E. Usdin, R. Kvetnansky, and I. J. Kopin, eds.), Pergamon Press, Oxford, pp. 423–426.
Commarato, M. A., Brody, T. M., and McNeil, J. H., 1969, Can. J. Physiol. Pharmacol. 47: 511–514.
Steinberg, M. I., and Smith, C. B., 1971, J. Pharmacol. Exp. Ther. 176: 139–148.
Ross, S. B., and Renyi, A. L., 1971, J. Pharm. Pharmacol., 23: 276–279.
Lentzen, H., and Phillippu, A., 1977, Naunyn Schmiedebergs Arch. Pharmacol., 300: 25–30.
Dyck, L. E., 1978, Neurochem. Res., 3: 775–791.
Petrali, E. H., Boulton, A. A., and Dyck, L. E., 1979, Neurochem. Res. 4: 633–642.
Petrali, E. H., 1979, Neurochem. Res. 5: 297–300.
Stoof, J. C., Liem, A. L., and Mulder, A. H., 1976, Arch. Int. Pharmacodyn. Ther. 220: 62–71.
Dyck, L. E., and Boulton, A. A., 1980, Res. Commun. Psychol. Psychiatry Behay., 5: 61–78.
Boulton, A. A., and Dyck, L. E., 1980, Res. Commun. Psycho!. Psychiatry Behay. 5: 79–94.
Arbilla, S., Kamal, L. A., and Langer, S. Z., 1981, Br. J. Pharmacol. 72: 499P - 500 P.
Dyck, L. E., Boulton, A. A., and Jones, R. S. G., 1980, Eur. J. Pharmacol. 68: 33–40.
Dyck, L. E., 1981, Eur. J. Pharmacol. 69: 371–374.
Juorio, A. V., 1979, Brain Res. 179: 186–189.
Dyck, L. E., 1981, Neurochem. Res. 6: 365–375.
Boulton, A. A., and Juorio, A. V., 1979, Biol. Psychol. 14: 413–419.
Randrup, A., Munkvad, 1., and Usden, P., 1963, Acta Pharmacol. Toxicol. ( Kbh. ) 20: 143–157.
Espelin, D. E., and Done, A. K., 1968, N. Eng. J. Med. 278: 1361–1365.
Costa, E., Groppetti, A., and Naimzada, M. K., 1972, Br. J. Pharmacol. 44: 742–751.
Carlsson, A., and Lindquist, M., 1963, Acta Pharmacol. Toxicol. 20: 140–144.
Andén, N.-E., Roos, B.-E., and Werdinius, B., 1964, Life Sci. 3: 149–158.
Laverty, R., and Sharman, D. F., 1965, Br. J. Pharm., 24: 759–772.
O Keeffe, R., Sharman, D. F., and Vogt. M., 1970, Br. J. Pharmacol. 38: 287–304.
Roos, B.-E., 1969, J. Pharm. Pharmacol. 21: 263–264.
Corrodi, H., Fuxe, K., and Ungerstedt, U., 1971, J. Pharm. Pharmacol. 23: 989–991.
Fuller, R. W., and Perry, K. W., 1978, J. Neural Transm. 42: 23–36.
Spector, S., Sjoerdsma, A., and Udenfriend, S., 1965, J. Pharmacol. 147: 86–97.
Huebert, N. D., and Boulton, A. A., 1978, Res. Commun. Chem. Path. Pharmacol. 22: 73–82.
Inwang, E. E., Mosnaim, A. D., and Sabelli, H. C., 1973, J. Neurochem. 20: 1469–1473.
Saavedra, J. M., and Axelrod, J., 1973, Proc. Natl. Acad. Sci. U.S.A. 70: 769–772.
Saavedra, J. M., Ribas, J., Swann, J., and Carpenter, D. 0., 1977, Science 195: 1004–1006.
Erspamer, V., 1948, Acta Pharmacy!. Toxicol. ( Kbli. ) 4: 224–227.
Erspamer, V., 1952, Nature 169: 375–376.
Kakimoto, Y., and Armstrong, M. D., 1962, J. Biol. Chem. 237: 422–427.
Juorio, A. V., 1978, Experientia 34: 1329–1330.
Walker, R. J., Ramage, A. G., and Woodruff, G. N., 1972, Experientia 28: 1173–1174.
Saavedra, J. M., Brownstein, M. J., Carpenter, D. O., and Axelrod. J., 1974, Science 185: 364–365.
Juorio, A. V., and Molinoff, P. B., 1974, J. Neurochem. 22: 271–280.
Barker, D. L., Molinoff, P. B., and Kravitz, E. A., 1972, Nature [New Biol.] 236: 61–63.
Robertson, H. A., and Juorio, A. V., 1976, Int. Rev. Neurobiol. 19: 173–224.
Hicks, T. P., and McLennan, H., 1978, Br. J. Pharmacol. 64: 485–491.
Hicks, T. P., and McLennan, H., 1980, Brain Res. 157: 402–406.
Karoum, F., Gitlin, J. C., and Wyatt, R. J., 1975, J. Neurochem. 25: 653–658.
Baldessarini, R. J., and Vogt, M., 1971, J. Neurochem. 18: 2519–2533.
Baldessarini, R. J., and Vogt, M.. 1972, J. Neurochem. 19: 755–761.
Durden, D. A., Juorio, A. V., and Davis, B. A., 1978, Quantitative Mass Spectrometry in Life Sciences II, Proceedings of the Second International Symposium (A. P. de Leenheer, R. R., Roncucci, and C. van Peteghem, eds.), Elsevier Scientific Publishing Company, Amsterdam, Oxford, New York, pp. 389–397.
Durden, D. A., Juorio, A. V., and Davis, B. A., 1980, Anal. Chem. 52: 1815–1820.
Hess, S. M., Redfield, B. G., and Udenfriend, S., 1959, J. Pharmacol. Exp. Ther. 127: 178–181.
Eccleston, D., Ashcroft, G. W., Crawford, T. B. B., and Loose, R., 1966, J. Neurochem. 13: 93–101.
Martin, W. R., Sloan, J. W., Christian, S. T. and Clements, T. H., 1972, Psychopharmacologia 24: 331–346.
Jones, R. S. G., and Boulton, A. A., 1980 Life Sci. 27: 1849–1856.
Wu, P. H., and Boulton, A. A., 1973, Can. J. Biochem. 51: 1104–1112.
Warsh, J. J., Chan. P. W., Godse, D. D., Coscina, D. V., and Stancer, H. C., 1977, J. Neurochem. 29: 955–958.
Young, S. N., Anderson. G. M., Gauthier, S., and Purdy, W. C., 1980, J. Neurochem. 34: 1087–1092.
Faurbye, A., 1968, Compr. Psychiatry 9: 155–177.
Connell, P. H., 1958, Amphetamine Psychosis, Chapman and Hall, London.
Snyder, S. H., 1973, Am. J. Psychiatry 130: 61–67.
Sandler, M., and Reynolds, G. P., 1976, Lancet 1: 70–71.
Potkin, S. G., Karoum, F., Chuang, L. W., Cannon-Spoor, H. E., Phillips, I., and Wyatt. R. J., 1979, Science 206: 470–471.
Wyatt, R. J., Gillis, J. C., Stoff, A. M., Majo, E. A., and Tinklenborg, J. R., 1977, Neuroregulators and Psychiatric Disorders (E. Usdin, D. A. Hamburg, and J. D. Barchas, eds.), Oxford University Press, New York, pp. 31–45.
Sandler, M., Ruthven, C. R. J., Goodwin, B. L., King, G. S., Pettit, B. R., and Reynolds, G. P., 1978, Commun. Psychopharmacol. 2: 199–202.
Sabelli, H. C., and Mosnaim, A. D., 1974, Am. J. Psychiatry 131: 695–699.
Sandler, M., Ruthven, C. R. J., Goodwin, B. C., Field, H., and Mathews. R., 1978, Lancet 2: 1269–1270.
Edwards, D. J., and Blau, K., 1973, Biochem. J. 132: 95–100.
Reynolds, G. P., Seakins, J. W. T., and Gray, D. O., 1978, Clin. Chico. Acta 83: 33–39.
Sandler, M., Youdim, M. B. H., and Hanington, E., 1974, Nature 250: 335–337.
Hanington, E., 1967, Br. Med. J. 2: 550–551.
Boulton, A. A., Majer, J. R., and Pollitt, R. J., 1967, Nature 215: 132–134.
Smith, I., and Kellow, A. H., 1969, Nature 221: 1261.
Boulton, A. A., and Marjerrison, G. L., 1972, Nature 236: 76–78.
Boulton, A. A., Marjerrison, G. L., and Majer, J. R., 1971, J. Acad. Sci. ( USSR ) 5: 68–70.
Bonham-Carter, S., Sandler, M., Goodwin, B. L., Sepping, P., and Bridges, P. K., 1978, Br. J. Psychiatry 132: 125–132.
Sandler, M., Ruthven, C. R. J., Goodwin, B. L., Reynolds, G. P., Rao, V. A. R., and Coppen, A., 1979, Nature 278: 357–358.
Ghose, K., Turner, P., and Coppen, A., 1975, Lancet 1: 1317–1318.
Pickar, A., Cohen, R. M., Murphy, D., and Fried, A., 1979, Am. J. Psychiatry 136: 1460–1463.
Blackwell, B., and Marley, E., 1964, Lancet 1: 530–531.
Scott, D. F., Moffett, A., and Swash, M., 1972, Epilepsia 13: 365–375.
Swash, M., Moffett, A. M., and Scott, A. F., 1975, Nature 258: 769–750.
Slingsby, J. M., and Boulton, A. A., 1976, J. Chromatogr. 123: 51–56.
Slingsby, J. M., 1975, Factors affecting urinary excretion of arylallylamines in a randomly selected psychiatric population, Ph.D. Thesis, University of Saskatchewan, Saskatoon.
Boulton, A. A., 1968, Prog. Neurogenet. 1: 437–441.
Huebert, N., and Boulton, A. A., 1979, J. Chromatogr. Biomed. Appl. 162: 169–176.
Davis, B. A., and Boulton, A. A., 1981, J. Chromatogr. Biomed. Appl. 222: 161–169.
Bremer, H. J., Jaenicke, U., and Lupold, D., 1969, Clin. Chim. Acta 23: 244–246.
Gjessing, L. R., and Lindeman, R., 1967, Lancet 2: 47–48.
Gibbons, 1. S. E., Seakins, J. W. T., and Ersser, R. S., 1967, Lancet 1: 877–878.
Duckworth, T., Bond, P. A., McKibbin, B., and Mitchell, E. C., 1973, Clin. Chim. Acta 43: 249–255.
Fischer, J. E., and Baldessarini, R. J., 1971, Lancet 2: 75–80.
Lam, K. C., Tall, A. R., Goldstein, G. B., and Mistilis, S. P., 1973, Scand. J. Gastroenterol. 8: 465–472.
Manghani, K. K., Lanzer, M. R., Billing, B. H., and Sherlock, S., 1975, Lancet 2: 943–946.
Rossi-Fanelli, F., Cangiano, C., Attili, A., Angelico, M., Cascino, A., Capocaccia, L., Strom, R., and Crifo, C., 1976, Clin. Chim. Acta 67: 255–261.
Capocaccia, L., Cangiano, C., Attili, A. F., Angelico, M., Cascino, A., and Fanelli, F. R., 1977, Clin. Chim. Acta 75: 99–105.
Baldessarini, R. J., and Fischer, J. E., 1977, Arch. Gen. Psychiatry 34: 958–964.
Berlet, H. H., Pscheidt, G. R., Spaid, J. K., and Himwich, H. E., 1964, Nature 203: 1198–1199.
Sullivan, J. L., Cottey, C. E., Basuk, B., Cavenar, J. D., Maltbie, A. A., and Zung, W. K., 1980, Biol. Psychiatry 15: 113–120.
Saavedra, S., and Axelrod, J., 1972, Science 175: 1365–1366.
Morgan, M., and Mandell, A. J., 1969, Science 165: 492–493.
Morgan, M., and Mandell, A. J., 1971, Nature [New Biol.] 230: 85.
Mandell, L. R., Rosenweig, S., and Kuehl, F., 1971, Biochem. Pharmacol. 20: 712–716.
Mandell, L. R., Ahn, A. S., Vandenheuvel, N. J. A., and Walker, R. W., 1972, Biochem. Pharmacol. 21: 1197–1200.
Young, S. N., and Lal, S., 1980, J. Neural Transm. 47: 153–161.
Young, S. N., 1980, Enzymes and Neurotransmitters in Mental Disease (E. Usdin, T. L. Sourkes, and Q. M. B. H. Youdim, eds.), John Wiley & Sons, New York, pp. 247–260.
Domino, E. F., Matthews, B. N., and Tait, S. K., 1979, Biomed. Mass Spectrom. 6: 331–334.
Yu, P. H., O’Sullivan, K. S., Keegan, D., and Boulton, A. A., 1980, Psychiatry Res. 3: 205–210.
Yu, P. H., and Boulton, A. A., 1979, Life Sci. 25: 31–36.
Boulton, A. A., 1980, Neurochemistry and Clinical Neurology (L. Battiskin, G. Hashin, and A. Lajtha, eds.), Alan R. Liss, New York, pp. 291–303.
Dismukes, R. K., 1979. Behay. Brain Sci. 2: 409–448.
Juorio, A. V., and Jones, R. S. G., 1981, J. Neurochem. 36: 1898–1903.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer Science+Business Media New York
About this chapter
Cite this chapter
Boulton, A.A., Juorio, A.V. (1982). Brain Trace Amines. In: Lajtha, A. (eds) Chemical and Cellular Architecture. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0614-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0614-7_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0616-1
Online ISBN: 978-1-4757-0614-7
eBook Packages: Springer Book Archive